Limited coverage drugs – perampanel

Last updated on September 26, 2024

Generic name 

perampanel

Strength

2 mg, 4 mg, 6 mg, 8 mg, 10 mg, 12 mg

Form

tablet

Special Authority criteria

Approval period

For the treatment of partial-onset seizures in adults and to be used:

  • as adjunctive therapy (used in combination with at least other anti-epileptic drug) for partial-onset seizures

AND

  • after at least other anti-epileptic medications have been tried without success (names of previously tried therapies and response must be indicated on Special Authority request)

Indefinite

For the treatment of primary generalized tonic-clonic seizures in adults and to be used:

  • as adjunctive therapy (used in combination with at least other anti-epileptic drug) for primary generalized tonic-clonic seizures

AND

  • after at least other anti-epileptic medications have been tried without success

Indefinite

Practitioner exemptions

  • No practitioner exemptions

Special notes

  • Special Authority requests should include documentation stating which other anti-epileptic drugs have been tried in adequate doses.
  • Patients should be under the care of a prescriber experienced in the treatment of epilepsy.

Special Authority requests